TLPH compared with UNCY: revenue, margins and what each company keeps, and the suppliers and customers both name

TLPHTalphera, Inc.

Mkt capRevenueRevenue

UNCYUnicycive Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

TLPHTalphera, Inc.

UNCYUnicycive Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TLPH: latest quarter is a loss; flow not drawable. UNCY: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TLPH 1

—Laboratoire Aguettantunlistedsupplier

Shared 0

No shared counterparties.

Only UNCY 1

—Shilpa Medicareunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

TLPH, solidUNCY, dashed

TLPHTalphera, Inc.

1.05▼−1.87%· post 1.04

Mkt cap$53.5MRevenue$1,000Q3 FY25

UNCYUnicycive Therapeutics, Inc.

3.75▼−1.56%· post 3.15

ClosedOct 30 '26

Mkt cap$100.7MRevenue—

Compare

ClosedOct 30 '26

TLPHTalphera, Inc.

UNCYUnicycive Therapeutics, Inc.

1.05▼−1.87%post 1.04

Price

3.75▼−1.56%post 3.15

$53.5M

Mkt cap

$100.7M

Q3 FY25$1,000

Revenue

—

TLPH1.05▼−1.87%vsUNCY3.75▼−1.56%ClosedOct 30 '26